Updated:
Keren Kesem
Keren Kesem manages the occupational pension fund for Israel's microbiologists and biochemists, operating since 1972 with an estimated $71M in assets.
Keren Kesem
Keren Kesem was founded in 1972 as the education and pension fund exclusively for Israel's professional community of microbiologists and biochemists. Headquartered in Petah Tikva, the fund is a legacy occupational vehicle whose mandate is defined not by a single family's wealth but by the collective retirement savings of a narrow scientific guild. The fund's creation aligns with Israel's mid-20th-century labor-union model of dedicated professional pension schemes. Keren Kesem deploys capital across a range of private-market strategies, including buyout, early-stage venture, seed and start-up investments, and late-stage expansion, per the fund's public record. The vehicle invests both in Israel and internationally, pursuing a hybrid allocation that blends direct company stakes with broader market exposures. While individual portfolio holdings are not publicly disclosed, the fund's dual domestic-international mandate and its small asset base point to a model built on co-investments, manager selection, and selective direct venture participation. With an estimated $71 million in assets under management, Keren Kesem is among the smallest institutional pension funds actively operating in Israel's capital markets. The fund's scale makes it a niche allocator, often participating alongside larger Israeli institutional investors in local venture rounds or placing commitments into global private equity vehicles. Unlike broad public pension systems, its extremely focused membership base generates predictable, slow-growing asset flows that shape a patient-liability profile. Keren Kesem's structural differentiator is its exclusivity: it is bound to a specific professional constituency—practicing microbiologists and biochemists—making it one of the few remaining occupational pension schemes in Israel that still operates as a closed membership fund. This narrow participant base creates a governance model where the beneficiaries and the investment policy exist in a direct fiduciary loop, unmediated by public or multi-employer consolidation pressures that have absorbed most similar plans over the past three decades.
General information
Firm type
Pension Fund
Year founded
1972
AUM
Under $100M (Altss estimate)
Location
Region
Middle East
Country
Israel
City
Petah Tikva
Corporate office
Petah Tikva, Israel
Sector focus
Frequently asked questions
Who is eligible to participate in Keren Kesem's fund?
The fund is closed to professionals in the fields of microbiology and biochemistry practicing in Israel. It was established in 1972 specifically to serve this occupational group and does not operate as an open-market pension product. The closed-member structure is a defining feature of the vehicle's governance.
What is Keren Kesem's investment mandate?
Keren Kesem allocates across private equity, venture capital, and expansion-stage investments, both in Israel and internationally. Its public record indicates activity in buyout, early-stage funding, seed rounds, and late-stage venture. The fund's small asset base means direct co-investments and fund-of-funds commitments are the likely primary implementation methods.
How large is Keren Kesem and does it publicly disclose its AUM?
Keren Kesem does not publicly disclose a precise AUM figure. Altss estimates the fund's assets at roughly $71 million, classifying it in the under-$100 million band. It is one of the smallest institutional pension vehicles in Israel's financial system.
Is Keren Kesem connected to a specific family office or sponsor?
No. The fund is not a family office. It is a member-owned occupational pension scheme originally established for Israel's biochemistry and microbiology professionals. No single family or corporate sponsor controls the entity.
Does Keren Kesem invest primarily in Israel or abroad?
Per the fund's own description, it invests in Israel and outside of it. The dual geographic mandate is maintained despite the fund's small size, likely executed through managed funds for international exposure and a mix of direct and fund commitments for domestic allocations.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: